Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
IXJ iShares Global Healthcare ETF daily Stock Chart
IXJ [NYSE]
iShares Global Healthcare ETF
Financial | Exchange Traded Fund | USA
statements
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.52%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.69%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter7.46%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-0.06%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year11.93%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range51.07 - 71.09 Perf YTD0.74%
Dividend1.02 P/FCF- EPS past 5Y- ROI- 52W High-2.57% Beta-
Dividend %1.47% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low35.62% ATR1.07
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)52.04 Volatility1.20% 1.58%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.26 Prev Close69.25
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume178.57K Price69.26
Recom- SMA200.76% SMA500.82% SMA2004.82% Volume46,855 Change0.01%
Nov-04-19 11:20AM  
Eaton Vance Worldwide Health Sciences Fund Buys 2 Stocks
GuruFocus.com
Aug-06-19 03:45PM  
The Top 5 Buys of the Eaton Vance Worldwide Health Sciences Fund
GuruFocus.com
Jun-12-19 08:28AM  
Traders Look to Buy Global Health Care Stocks
Investopedia
Aug-09-18 12:45PM  
Investors Flocked to Healthcare ETFs in July
ETF Trends
Aug-02-18 10:47AM  
5 Strong Healthcare ETFs to Buy
InvestorPlace
Mar-29-18 04:30PM  
BlackRock Announces Share Split for Four iShares ETFs
Business Wire
Jan-25-18 09:38AM  
Analysts Estimates for Pfizers 4Q17 Earnings
Market Realist
Jan-18-18 05:30PM  
Merck & Co.s Business Segments and Performance in 3Q17
Market Realist
Jan-09-18 10:48AM  
7 Best Healthcare ETFs for 2018
InvestorPlace
Oct-02-17 01:27PM  
9 Million American Children Lost Funding For Their Insurance
Benzinga
Sep-12-17 09:06AM  
Assessing Mercks Immunology and Cardiovascular Franchise in 2Q17
Market Realist
Sep-11-17 08:36AM  
Whats Gilead Sciences Valuation?
Market Realist
Sep-05-17 09:07AM  
Performance of AstraZenecas CVMD Segment in 2Q17
Market Realist
Aug-29-17 03:05PM  
Bristol-Myers Squibbs Revenues in 2Q17
Market Realist
Aug-23-17 09:07AM  
Inside Incytes Jakafi Performance in 2Q17
Market Realist
Jul-26-17 03:09PM  
AstraZenecas 2Q17 Earnings: Analysts Estimates
Market Realist
Jul-25-17 07:37AM  
Major Developments for Johnson and Johnson
Market Realist
Jul-18-17 10:37AM  
Analyst Ratings and Recommendations for Novartis Post 2Q17
Market Realist
Jul-17-17 10:37AM  
Inside Allergans International Business
Market Realist
Jul-11-17 07:37AM  
How Celgene Stock Performed in 2Q17
Market Realist
Jul-05-17 07:37AM  
Johnson & Johnsons Medical Devices Business in 1Q17
Market Realist
Jul-04-17 10:36AM  
Performance of Mercks Diabetes Drugs in 1Q17
Market Realist
Jun-28-17 09:06AM  
Pfizers Geographical Performance in 1Q17
Market Realist
Jun-22-17 07:36AM  
Changes in Bristol-Myers Squibbs Profitability 1Q17
Market Realist
Jun-05-17 10:36AM  
Performance of Elanco in 1Q17
Market Realist
May-31-17 07:36AM  
Exploring the Performance of AstraZenecas CVMD Segment in 1Q17
Market Realist
May-30-17 05:05PM  
Johnson & Johnsons Business Segments in 1Q17
Market Realist
May-29-17 02:05PM  
AstraZenecas Segment-by-Segment Performance in 1Q17
Market Realist
May-25-17 09:06AM  
Performance of Mercks Animal Health Segment in 1Q17
Market Realist
May-08-17 11:26AM  
Allergans 1Q17 Earnings: Analysts Estimates
Market Realist
May-05-17 05:36PM  
Pfizers Geographical Performance in 1Q17
Market Realist
Apr-26-17 09:07AM  
GlaxoSmithKlines 1Q17 Estimates: Consumer Healthcare
Market Realist
Apr-25-17 04:28PM  
What Analysts Expect of Bristol-Myers Squibbs 1Q17 Earnings
Market Realist
Apr-24-17 07:38AM  
Novartiss 1Q17 Estimates for Sandoz
Market Realist
Apr-13-17 03:05PM  
Johnson & Johnsons Revenue Estimates: Expect Growth!
Market Realist
Apr-10-17 09:06AM  
Examining Gilead Sciences 1Q17 Performance
Market Realist
Apr-07-17 01:35PM  
Assessing Johnson & Johnsons 1Q17 Performance
Market Realist
Apr-05-17 07:36AM  
Must-Know Corporate and Pipeline Developments for Pfizer
Market Realist
07:36AM  
Must-Know Corporate and Pipeline Developments for Pfizer
Apr-03-17 07:36AM  
How Eli Lillys New Products Performed in 2016
Market Realist
07:36AM  
How Eli Lillys New Products Performed in 2016
Mar-14-17 07:36AM  
Johnson & Johnsons Pharmaceuticals Segment
Market Realist
07:36AM  
Johnson & Johnsons Pharmaceuticals Segment
Mar-02-17 07:37AM  
How Gileads Other Products Fared in 2016
Market Realist
07:37AM  
How Gileads Other Products Fared in 2016
Feb-28-17 09:07AM  
Strong Performance of AstraZenecas Brilinta and Farxiga in 2016
Market Realist
09:07AM  
Strong Performance of AstraZenecas Brilinta and Farxiga in 2016
Feb-24-17 04:53PM  
Pfizers Valuation after Its 4Q16 Earnings Release
Market Realist
04:53PM  
Pfizers Valuation after Its 4Q16 Earnings Release
09:07AM  
Eli Lilly & Co.s Endocrine Franchise
Market Realist
09:07AM  
Eli Lilly & Co.s Endocrine Franchise
Jan-31-17 09:08AM  
Analyzing Merck & Co.s Revenue Estimates in 4Q16
Market Realist
09:08AM  
Analyzing Merck & Co.s Revenue Estimates in 4Q16
07:37AM  
Opdivo: Bristol-Myers Squibbs Blockbuster Oncology Drug
Market Realist
07:37AM  
Opdivo: Bristol-Myers Squibbs Blockbuster Oncology Drug
Jan-30-17 09:06AM  
Exploring JNJs 2017 Profitability and Financial Guidance
Jan-26-17 03:05PM  
Johnson & Johnsons 4Q16 Performance by Business Segment
07:37AM  
How Will Eli Lillys Neuroscience Franchise Fare in 4Q16?
Jan-24-17 10:38AM  
How Bristol-Myers Squibbs Oncology Drug Performed in 4Q16
Jan-23-17 10:37AM  
Novartiss 4Q16 Estimates: How Could Sandoz Perform?
Jan-20-17 07:38AM  
Why Johnson & Johnsons 4Q16 Revenues Could Grow
Jan-12-17 11:49AM  
The 'Trump Rally' in Stocks Is Ending -- Here's How You Can Profit
Dec-30-16 07:38AM  
Exploring GlaxoSmithKlines Business Segments
Dec-29-16 05:05PM  
GlaxoSmithKlines Revenue Trend
Dec-09-16 08:06AM  
How Does Johnson & Johnsons Valuation Compare to Its Peers?
Dec-01-16 08:05AM  
Inside Mercks Business Segment-Wise Performance
Nov-29-16 01:26PM  
Allergans Valuation Compared to Its Peers
Nov-23-16 11:04AM  
Inside Eli Lillys Neuroscience Franchise
Oct-28-16 06:02PM  
What Can We Expect of Pfizers 3Q16 Earnings?
Oct-24-16 10:05AM  
Novartiss 3Q16 Estimates: How Has Sandoz Performed?
10:04AM  
Word on the Street about Mercks Animal Health Segment
Oct-21-16 11:04AM  
How Did Johnson & Johnsons Pharmaceutical Segment Do in 3Q16?
Oct-19-16 11:05AM  
Eli Lilly and Co.s 3Q16 Estimates: Neuroscience Franchise
Oct-14-16 02:04PM  
Johnson & Johnsons Pharmaceuticals Segment: 3Q16 Estimates
Sep-19-16 11:04AM  
AstraZeneca Is Taking Steps to Improve Its Position in Oncology
Sep-16-16 10:04AM  
Roche Sees Soaring Revenue from Its Bladder Cancer Treatment
Sep-09-16 06:04PM  
What Investors Can Glean from GlaxoSmithKlines Revenue Trend
Aug-30-16 12:19PM  
Is Johnson & Johnsons Valuation High Compared to Its Peers?
Aug-27-16 12:01AM  
[$$] Why Investors Should Think Global
Barrons.com
Aug-25-16 11:04AM  
AstraZenecas Recent Product Developments
08:04AM  
AstraZeneca and Its Oncology Segments Growth in 2Q16
Aug-24-16 08:04AM  
How Crestor Weakened AstraZenecas CVMD Segment in 2Q16
Aug-16-16 11:04AM  
Remicade Is Driving Down Mercks Immunology Franchise
Aug-04-16 11:04AM  
How Are Eli Lillys New Products Performing?
Aug-03-16 09:04AM  
Revenues from Eli Lillys Cymbalta Are Depressed Internationally
Aug-01-16 10:32AM  
What to Expect from Pfizers 2Q16 Earnings
Jul-22-16 01:14PM  
How Did JNJs Pharmaceutical Segment Fare in 2Q16?
01:07PM  
Understanding Lillys New Product Expectations for 2Q16
01:07PM  
Inside Lillys 2Q16 Estimates for Its Neuroscience Franchise
Jul-06-16 09:05AM  
Why AbbVie Continues to Explore Imbruvica for Diffuse Large B-Cell Lymphoma
Jun-26-16 07:21AM  
The 5 Best Healthcare ETFs
Motley Fool
Jun-09-16 10:11AM  
The Probable Reason Behind Cerus Corp's 11.2% Drop in May
Motley Fool
Jun-06-16 09:07AM  
AstraZenecas Key Focus: Oncology
Jun-01-16 12:58PM  
Whats AstraZenecas Largest Revenue Contributor?
May-27-16 11:37AM  
Government Study: Cellphone Radiation Linked To Cancer
May-18-16 03:52PM  
Recovery for the Manufacturing Sector Is Not Yet in Sight
May-16-16 08:07AM  
Why Is Remicade Driving Down Mercks Performance?
May-13-16 03:07PM  
How Is Gardasil Driving Mercks Vaccines Business?
01:50PM  
Thematic ETFs: Smarter Than Regular Smart Beta ETFs?
May-11-16 03:48PM  
What Factors Are Impacting Mercks Growth?
The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.
open in yahoo | open in google